Weight Fluctuation After Breast Cancer Treatment
Recruitment status was Active, not recruiting
This study aims to identify and quantify the factors associated with excess weight gain following treatment for breast cancer. It is believed that breast cancer patients gain more than 4% of their weight at diagnosis which is likely accompanied by an increase in body fat and waist circumference. It is further thought that this excess weight and increase in body fat and waist circumference are associated to tumour characteristics, chemotherapy, menopause status at diagnosis and the presence of genes related to obesity. It is also thought that women treated with chemotherapy have higher levels of glucose and insulin.
|Study Design:||Observational Model: Cohort
Time Perspective: Cross-Sectional
|Official Title:||Weight Fluctuation After Breast Cancer Treatment|
- To provide evidence of the relationship between weight gain following diagnosis of breast cancer and tumour characteristics, chemotherapy, menopause status at diagnosis and the presence of genes related to obesity. [ Time Frame: 12-18 months. ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
Fasting blood sample to determine participants genotype, insulin and glucose levels.
|Study Start Date:||August 2008|
|Estimated Primary Completion Date:||January 2013 (Final data collection date for primary outcome measure)|
Diagnosed with breast cancer 1/1/2003 - 31/12/2007.
Procedure: Fasting blood sample.
Fasting blood sample taken following informed consent for genotyping, glucose and insulin levels.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00991653
|Principal Investigator:||Tamas Hickish||Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust|